The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...
BALA CYNWYD, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
Larimar Therapeutics, Inc. has announced a refined timeline for submitting a Biologics License Application (BLA) for its treatment nomlabofusp, aimed at addressing Friedreich's Ataxia (FA). Based on ...
A quick look at FDA’s 2025 transparency moves, what CRLs are (and aren’t), how FAERS works and its limits, who can report, and where the agency is applying AI.
GlobalData’s enhanced AI-powered Likelihood of Approval (LoA) model boosts its predictive power, providing probability of a ...
The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback